当前位置:
首页
>
产品中心 >
exosome_research >
Enzolifesciences/GCDFP-15 (human) monoclonal antibody (D6)/ALX-801-051-L001/1ml
Enzolifesciences/GCDFP-15 (human) monoclonal antibody (D6)/ALX-801-051-L001/1ml
商品编号:
ALX-801-051-L001
品牌:
enzolifesciences
市场价:
¥18100.00
美元价:
10860.00
产品分类:
外泌体研究
公司分类:
exosome_research
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product Specification:
Alternative Name: | BRST-2 |
Clone: | D6 |
Host: | Mouse |
Isotype: | IgG2a |
Immunogen: | GCDFP-15 (gross cystic disease fluid protein-15; BRST-2). |
UniProt ID: | P12273 |
Species reactivity: | Human |
Applications: | IHC (PS) |
Recommended Dilutions/Conditions: | Immunohistochemistry (paraffin sections): Formalin-fixed, paraffin-embedded tissues; pre-treatment not required; suggested dilution: ≥1:40 for biotin based detection. For optimal staining, incubate primary antibody 20-60 minutes at room temperature). Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. |
Application Notes: | This antibody is heat sensitive. Paraffin sections that have been heat fixed at 60°C may lose antibody binding site. |
Positive Control: | Human axilla or breast carcinoma. |
Formulation: | Liquid. In 0.01M PBS containing 1% BSA and 0.1% sodium azide . |
Handling: | Avoid freeze/thaw cycles. |
Shipping: | Shipped on Blue Ice |
Short Term Storage: | +4°C |
Long Term Storage: | -20°C |
Scientific Background: | Gross cystic disease is a common premenopausal disorder in which gross cysts are the predominant pathologic lesion. It is characterized by production of a fluid secretion which accumulates in the breast cysts. Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15kDa monomer protein, GCDFP-15. The cells within the body that produce GCDFP-15 appear to be restricted primarily to those with apocrine function. Studies have found GCDFP-15 to be a highly specific and sensitive marker for breast cancer. GCDFP-15 is expressed by apocrine sweat glands, eccrine glands (variable), minor salivary glands, bronchial glands, metaplasmic epithelium of the breast, benign sweat gland tumors of the skin and the serous cells of the submandibular gland. Breast carcinomas (primary and metastatic lesions) with apocrine features express GCDFP-15. GCDFP-15 is positive in extramammary Paget's Disease. Other tumors tested are negative. |
品牌介绍
Product categoriesPharmaceuticals And Biochemic
CAS 6090-98-8
conduritol F
CAS 20544-37-0
2,4,8,10-Tetraoxa-3,
CAS 135564-23-7
Benzaldehyde, 4-amin
CAS 34169-62-5
2-Naphthalenesulfoni
CAS 6305-52-8
2-Butyldecahydronaph
CAS 10074-13-2
1,3-Benzenedimethane
CAS 84434-05-9
Acetic acid,2-[(9-ox
CAS 104748-51-8
Avilamycin K
CAS 5539-08-2
Ergoline-8-carboxyli
CAS 1242-56-4
Androst-1-en-3-one,1
CAS 52978-30-0
(1R,2R,3E,5E,15E,17E
CAS 24471-48-5
2-Pyrenemethanol
CAS 39325-01-4
Picibanil
CAS 244290-68-4
Quinolinium, 7-[(die
CAS 80584-90-3
1H-Benzotriazole-1-m
CAS 65193-87-5
Butanoic acid, 3-oxo
CAS 3563-92-6
Zylofuramine
CAS 24979-74-6
Phenol,4-ethenyl-, p
CAS 1067-48-7
1-Pentanamine, 5-(tr
CAS 62886-59-3
Sephadex-CM C-25,ion
View all products
Company Profile
Name:Enzo Life SciencesCategory:Corporation/Limited Liability CompanyTrade Category: ManufacturerRegistered Time: 1996Registered Capital: Above US$100 MillionLegal Representative:Employees:Address: TaksimWebsite: http://www.enzolifesciences.comProduct/Service: chemicals
Our breadth of scientific expertise coupled with unique technology platforms give us the flexibility to drive innovation throughout the entire research continuum. From life sciences research discovery efforts, through drug development, and into clinical research, our comprehensive range of products are designed to support your goals. When a standard catalog product does not meet your needs, talk to us about custom solutions; we can help
品牌分类
抗体
联络我们